Supported in part by National Institutes of Health/National Eye Institute Grants EY021818 (FAM), EY11008 (LMZ), and EY14267 (LMZ); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) grant Bolsas no Exterior (BEX) 1066/11-0; an unrestricted grant from Research to Prevent Blindness (New York, New York); and grants for participants' glaucoma medications from Alcon, Allergan, Pfizer, Merck, and Santen.
Disclosure: R. Lisboa, None; A. Paranhos Jr, None; R.N. Weinreb, Alcon (C), Allergan (C), Bausch & Lomb (C), Carl Zeiss Meditec, Inc. (C), Nidek (S), Topcon (C), Aerie (S), Genentech (S); L.M. Zangwill, Carl Zeiss Meditec, Inc. (F), Heidelberg Engineering (F); M.T. Leite, None; F.A. Medeiros, Carl Zeiss Meditec, Inc. (F), Heidelberg Engineering (F)